Apomorphine

Active ingredient description

Apomorphine is a direct stimulant of dopamine receptors and while possessing both D1 and D2 receptor agonist properties does not share transport or metabolic pathways with levodopa. Its actions on parkinsonian motor disability are likely to be mediated at post-synaptic receptor sites.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Apomorphine
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE07
Apomorphine
N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC07

Medicines

Apomorphine is the active ingredient of these drugs:

Drug
Countries

Austria Cyprus Estonia Finland Ireland

France Tunisia

United States

Australia

Lithuania

Austria Estonia Finland Ireland Lithuania

France

Canada United States

Australia Canada New Zealand

South Africa

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 267.322 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 41372-20-7
CAS Substance: 58-00-4
DrugBank Drug: DB00714
KEGG Drug: D02004
RxNorm Ingredient: 1043
SNOMED-CT Concept: 387375001
Apomorphine (substance)
UNII Identifier: N21FAR7B4S
APOMORPHINE